This Holi, Piramal Finance took a creative leap with an AI-generated film, Masti Ke Rang, Neeyat Ke Sang. Crafted entirely by the in-house team, this was a playful experiment to see how AI could ...
Eisai and Biogen's Alzheimer's therapy Leqembi will be priced at $26,500 per year – a little less than misfired predecessor Aduhelm – after getting conditional authorisation for the drug from ...
The FDA has started its review of a subcutaneous injection formulation of Eisai and Biogen's Alzheimer's drug Leqembi that could allow patients to receive maintenance doses at home, rather than in ...
In 2024, drugmakers delivered breakthrough treatments in conditions that had seen little progress for decades—and helped make existing therapies more accessible. Approved in July, Eli Lilly’s ...
Exclusive: Former Cruise CEO Vogt's robotics startup valued at $2 billion in new funding, sources say Kyle Vogt, former CEO of self-driving car company Cruise, has raised $150 million in a new ...
'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...
Now participants have been switched from an earlier experimental drug to Leqembi, an IV treatment approved in the U.S., to try to answer the obvious next question. "What we want to determine over the ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. In the rapidly evolving job ...
After hours: March 21 at 7:27:47 PM EDT Loading Chart for BIIB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results